In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries. He discusses XRC’s investment strategy, the criteria it uses to decide which start-up and early stage companies to work with, and the sectors that he sees as ripe for innovation.
Video Forum: Pano Anthos, XRC Ventures
In this week’s Video Forum, Pano Anthos, founder and managing director of XRC Ventures, talks about the investment firm’s work in the retailing, health care technology and CPG industries.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Changing Consumer Expectations Reshape O-T-C Category
Helping people make informed decisions about their health gains urgency at Haleon.
Buzz Health and Push Health team to show patients the best available Rx price before they fill
Buzz Health's RxCompare integration will compare multiple discount cards across pharmacies and display the best available price in the Push Health app.
Camber launches generic clomiphene citrate tablets
Camber launched generic Clomid (clomiphene citrate 50 mg) in 10- and 30-count cartons.
GLP-1 users drive new health and wellness purchasing trends
New Circana research shows GLP-1 households shifting spending on food, health tech and wellness as treatment progresses.